Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex
Clinical trial NCT04677569 · COMPLETED
Trial details
- NCT number
- NCT04677569
- Sponsor
- Insmed Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2025-11-21
- Enrollment
- 425
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.